Effect of Ruboxistaurin on Visual Loss in Patients with Diabetic Retinopathy

Oral ruboxistaurin treatment reduced vision loss, need for laser treatment, and macular edema progression, while increasing occurrence of visual improvement in patients with nonproliferative retinopathy.